000 01542 a2200433 4500
005 20250517005445.0
264 0 _c20160929
008 201609s 0 0 eng d
022 _a1648-9144
024 7 _a10.1016/j.medici.2014.10.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRamanauskienė, Eglė
245 0 0 _aEarly development of endocrine and metabolic consequences after treatment of central nervous system tumors in children.
_h[electronic resource]
260 _bMedicina (Kaunas, Lithuania)
_c2014
300 _a275-80 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBrain Neoplasms
_xradiotherapy
650 0 4 _aChild
650 0 4 _aCombined Modality Therapy
_xadverse effects
650 0 4 _aEndocrine System Diseases
_xepidemiology
650 0 4 _aFemale
650 0 4 _aGlioma
_xradiotherapy
650 0 4 _aHumans
650 0 4 _aHydrocortisone
_xdeficiency
650 0 4 _aHypothyroidism
_xepidemiology
650 0 4 _aIncidence
650 0 4 _aMale
650 0 4 _aMedulloblastoma
_xradiotherapy
650 0 4 _aMetabolic Diseases
_xepidemiology
650 0 4 _aObesity
_xepidemiology
650 0 4 _aPrevalence
650 0 4 _aReceptor, IGF Type 1
_xdeficiency
650 0 4 _aThyroid Gland
_xphysiopathology
700 1 _aLabanauskas, Liutauras
700 1 _aVerkauskienė, Rasa
700 1 _aSileikienė, Rima
773 0 _tMedicina (Kaunas, Lithuania)
_gvol. 50
_gno. 5
_gp. 275-80
856 4 0 _uhttps://doi.org/10.1016/j.medici.2014.10.006
_zAvailable from publisher's website
999 _c24440886
_d24440886